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A CASE STUDY OF TECHNOLOGY TRANSFER: CARDIOLOGY
On October 24, 1971, during the Chicago Bears-Detroit Lions Na-
tional Football League game, the Lion's wide receiver suffered an
injury late in the fourth quarter. The backup man, Chuck Hughes,
entered the game with about ten minutes to play. With less than two
minutes remaining, Hughes hauled in a thirty-two yard pass from
quarterback Greg Landry and was immediately brought down in a
crushing tackle by two Bears defenders. It was his first pass recep-
tion of the season. Two plays later, he returned to the huddle after.
running a deep pass pattern. It was the final huddle for Hughes. As
the next play was being called, Hughes suddenly clutched his chest and
toppled face down on the turf. An hour later, he was pronounced dead
at Henry Ford Hospital (New York Times, October 25, 1971 and News-
week, November 8, 1971).
An autopsy revealed that Hughes had suffered an attack of arterio-
sclerosis--an acute coronary thrombosis, a heart attack. Physicians
for the Detroit Lions said that the arteriosclerosis heart disease had
been coming on for some time, with no signs. The disease is charac-
terized by abnormal thickening and hardening of the arterial walls,
eventually shutting off the blood flow to the heart. This hardening of
the arteries had severely restricted Hughes' blood flow. Since the
disease often cannot be easily detected, Hughes probably was not
aware of. it. In fact, he had been hospitalized with pains after being
tackled hard in a pre-season exhibition game, but a cardiogram, an
arteriogram, and other laboratory tests revealed nothing. Before
playing against the New England Patriots on September 26, Hughes
was quoted as saying:
I don't know what's wrong, I've had sharp pains in my
stomach and my chest and they've made all sorts of
tests, but nobody seems to be able to figure them out.
I want to play though. They aren't that bad (New York
Times, October 26, 1971).
This story is unusual because Chuck Hughes was only twenty-eight
years old and a professional athlete in top physical condition. It is
not unusual, however, when one considers that each year in the UAited
States more than 840, 000 persons die of arteriosclerosis (National
Heart and Lung Institute, National Program, 1973) and at least 250, 000
persons are victims of sudden heart failure (U. S. News & World
Report, September 18, 1972).
2An Overview of Cardiology
Cardiology, the study of the healthy and diseased heart and blood
vessels, has a history as old as man's interest in his own bodily func-
tions. Written records from the early days of the Greek Empire
document this interest, although it is certain that earlier civilizations,
such as the Egyptians and Mesopotamians, possessed much knowledge
which probably influenced the Greeks. The greatest of the Greek
works on the heart and circulatory system, On Anatomical Procedures,
was compiled by Galen in the second century, A. D. (Baldry, 1971).
His teachings were accepted as an accurate account by Christian, Jew-
ish and Moslem theologians. This acceptance sanctified the ideas
proposed to such an extent that any attempt to challenge or contradict
them was considered blasphemous and heretical.
Thus, study of the heart evolved quite slowly until 1543 when
Andreas Vesalius published Humani Corporis Fabrica, an attack of
Galen's theories (Baldry, 1971). Thereafter, with the coming of the
Rennaisance, more and more accurate knowledge, such as Harvey's
description of the circulatory system, began to appear.
Still, it was not until late in the nineteenth century that cardiology
became recognized as the field it is today. The first heart surgery, in
1895, opened a whole new frontier. Slowly, heart surgery became
accepted in medical practice; more venturesome operations, such as
the first successful ligation of the congenital anomaly, patent ductus
arteriosus, by Dr. Robert Gross in 1939, were undertaken.
Today, heart surgery has progressed by such miraculous bounds
that even open-heart surgery is commonplace in modern hospitals.
Several factors are responsible for the successful operations now
being performed:
* More delicate, highly specialized tools and materials
developed for actual cutting and repair, or substitu-
tion, of heart and artery tissue;
* Improved diagnostic tools;
* More sophisticated equipment for blood analysis;
* Improved methods of administering anesthesia;
* Advances in heart-lung machines, making them
more responsive to patient needs; and
* New post-operative techniques for monitoring
vital functions (U. S. News & World Report,
September 18, 1972).
Cardiovascular Research
Cardiovascular disease is the number one killer in the United
States, accounting for more than one million deaths a year. In 1970,
for example, cardiovascular disease accounted for 52. 5 percent of all
deaths in the United States; in comparison, cancer, the number two
killer, accounted for only 17. 2 percent and motor vehicle mortalities
for only 2.7 percent (U. S. Department of Commerce, 1972). It is
estimated that fifteen million Americans between the ages of eighteen
and seventy-nine suffer from heart disease, with about two million of
those becoming seriously handicapped (Science Digest, April 1972). In
addition, cardiovascular disease is estimated to cost more than thirty
billion dollars annually in lost wages, lost productivity and in medical
expenses. If heart and blood vessel disease could be eliminated, it
would mean an increase of almost eleven years in the average life
expectancy in this country ("National Heart, Blood Vessel, Lung and
Blood Act of 1972, " September 19, 1972).
The view of cardiovascular research today is essentially the same
as that of twenty years ago, as exemplified in the following statements:
Important discoveries about heart disease, now being
made, are expected before long to save the lives of
thousands of people in this country. A flood of new
leads, hotly pursued in laboratories all over the
United States, is beginning to produce some of the
answers to heart and circulation diseases that kill
700, 000 people in the U. S. every year (U. S. News
& World Report, September 14, 1951).
The biggest push yet to unlock the mysteries of heart
attacks is now underway. Funded by a $14 billion,
three-year federal grant, it will focus on both basic
and clinical research, on long-range prevention as
well as cure . . . . The new offensive is necessary
4because the stubborn enemy has not yielded an inch in
20 years. Despite all the publicity about transplants
and all the warnings about exercise, smoking, diet
and stress, heart attacks still fell a million persons
a year, nearly 700, 000 of them fatally--the same
death rate as in 1950 (Today's Health, February 1973).
These statements reflect the quandary in which those conducting
heart research find themselves. The growing battle against heart
disease can be traced by examining the yearly appropriations of the
National Heart and Lung Institute (see Figure 1). Efforts and money
have increased, and, yet, the long awaited "breakthroughs" have not
appeared.
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Figure 1. National Heart and Lung Institute Appropriations,
FY 1950 - 1974. [Source: National Heart and
Lung Institute, 1973.]
5It would be extremely inaccurate, however, to say that no progress
has been made. Advances are continually emerging from the labora-
tories and hospitals, indicating that eventually the problem of heart
disease can be controlled. Some of these advances are:
* Safely removing blood clots, either by cutting or
reaming;
* "Blowing out" harmful masses of fatty tissue by
introducing gas under pressure into an artery;
* Using new synthetic materials to patch weak
places in arteries;
* Bypassing plugged or weakened arteries with new
artificial substitutes, or with blood vessels from
other parts of the body;
* Replacing malfunctioning heart valves with
long-lasting artificial substitutes, or with
human transplants;
* Installing electrically powered pacemakers for
hearts with weak, erratic beats;
* Using drugs to increase or improve blood flow; and
* Inserting intra-aortic balloon pumps, which assist
circulation by inflating and deflating when dam-
aged heart muscles fail (U. S. News & World
Report, September 18, 1972 and Good House-
keeping, May 1972).
The future of cardiovascular research is unlimited. Two of the
most promising developments could be the artificial heart and the use
of preventative drugs which reduce fatty substances in the blood, par-
ticularly cholesterol. Along with these, the development of a nonin-
vasive technique of detecting arteriosclerotic changes in vessels is
being sought so that progression of the disease can be traced (Science,
September 7, 1973).
6Government participation. The Congress of the United States rec-
ognized the need for expanded and directed cardiological research by
enacting the "National Heart, Blood Vessel, Lung and Blood Act of
1972. " This act gives the National Heart and Lung Institute the author-
ity to coordinate the research activities of all government agencies in
the areas of cardiology, pulmonary function and hematology. The
Institute's four primary goals are to promote health, prevent disease,
treat disease and restore health. The overall strategy for the National
Heart, Blood Vessel, Lung and Blood Program is depicted in Figure 2.
Figure 2 National Heart, Blood Vessel, Lung and Blood
Program Strategy. [Source: National Heart,
Blood Vessel, Lung and Blood Program, 1973.]
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7Four major groups have been recognized as contributing to the
research activities of this national program: (1) the National Heart
and Lung Institute; (2) other institutes and divisions of the National
Institutes of Health; (3) federal agencies exclusive of the National In-
stitutes of Health;* and (4) voluntary organizations. As one of the
federal agencies carrying out specific research in the area of heart
and blood vessels, the National Aeronautics and Space Administration
has contributed in a substantial way to the basic knowledge of cardi-
ology.
The NASA role. The National Heart and Lung Institute recognizes
that:
NASA supports related mission-oriented research
directed at understanding, measuring, and controlling
body functions and mechanisms in diverse environ-
mental states. Instrumentation and techniques have
been and are being developed directly applicable to
the cardiovascular and pulmonary systems (National
Heart and Lung Institute, 1973).
An inventory of NASA-supported research projects in the area of
cardiology has been compiled by the National Heart and Lung Institute
and is summarized in Table 1. An examination of these projects
reveals why NASA's research is so uniquely important: NASA is one
of the few agencies carrying out research that concentrates on study-
ing the normal or healthy heart. The vast majority of all other cardi-
ological research involves studying the diseased circulatory system.
It is necessary, however, to advance knowledge concerning the physi-
ology and function of the normal circulatory system in order to develop
a better understanding of the diseased one (Johnson, 1973).
Department of Agriculture, Atomic Energy Commission, Department
of Defense, Environmental Protection Agency, Food and Drug Admin-
istration, Health Services and Mental Health Administration, National
Aeronautics and Space Administration, National Science Foundation,
Social and Rehabilitation Service, Social Security Administration,
Department of Transportation and Veterans Administration.
8TABLE 1. PROGRAM ANALYSIS - NATIONAL AERONAUTICS
AND SPACE ADMINISTRATION - FISCAL YEAR 1972*
RESEARCH PROJECTS
* Advanced cardiovascular bioinstrumentation in man
* A feasibility study of a microwave regional blood volume
sensing technique
* Noninvasive measurement of central venous pressure
* Ultrasonic Doppler measurement of renal artery blood flow
* Study for vectorcardiogram display system and blood pres-
sure monitoring systems
* Feasibility study of limb volume measuring systems
* Neurohumoral control of cardiovascular responses
* Regulation of blood flow distribution
* Biocybernetic model of the cardiovascular system during
headward and footward acceleration
* Studies of left ventricular function and vasodepressor
syncope
* Investigation of atraumatic techniques for monitoring
cardiovascular status and conditioning
* Cardiovascular hemodynamics in man
* Control of vascular distensibility
* Effects of space flights on vascular permeability
Source: National Heart, Blood Vessel, Lung and Blood Program, 1973.
NASA also serves the advancement of cardiological research by
providing impetus to the medical community. The demands of the
aerospace program, such as prolonged weightlessness, required that
knowledge of basic human physiology be rapidly expanded. Thus, it is
estimated that such knowledge is at a more advanced level than if the
aerospace program had not existed (Leach, 1973).
Selected NASA Contributions to Cardiology
Activities of the National Aeronautics and Space Administration in
the area of cardiology have come about because of the declared mission
of the Space Life Sciences Program "to keep man alive and in good
functional order and to support and aid him as he operates under the
physical stresses of the space environment" (U. S. Congress, House,
1973). These activities consist mainly of furthering man's knowledge
of basic human physiology and developing instrumentation and tech-
niques for monitoring vital life signs.
In the area of understanding basic human physiology, much of the
work is performed at American universities and colleges under NASA-
supported research grants. For example, one such program at
Harvard Medical School involves the study of renal blood flow. Some
of these grants relate directly to NASA's primary mission objectives
while others serve to provide scientific knowledge- -knowledge that is
important for a better understanding of man's functions and vital pro-
cesses, if not directly applicable to space flight (Johnson, 1973).
In attempting to understand how man reacts in a zero-gravity space
environment, NASA has developed instrumentation and techniques
devised to monitor vital functions on earth as well as in space. De-
velopment of instrumentation applicable to cardiology is a role of
great significance. At a National Academy of Engineering symposium
on "Engineering and Medicine, " Dr. James V. Maloney, Chief of the
Thoracic Surgery Division and Professor of Surgery, University of
California at Los Angeles School of Medicine, declared that:
the contributions to human health and welfare that
are going to be made by engineering in the next 5 years
will be as great or perhaps greater than the contribu-
tions of any individual specialty within the biological
sciences (National Academy of Engineering, 1970).
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NASA's work in bioinstrumentation consists mainly of advancing
the development of existing, but unsatisfactory, instrumentation
(Fryer, 1973). As observed:
Measurement instruments are now available for nearly
all physiological diagnostic indexes presently considered
useful by the medical profession. Pertinent data can be
acquired and transmitted reliably and conveniently al-
most anywhere. There is a need to enhance the speed,
accuracy, precision, and economy of treating these
measures and to extend their application on a
community-wide basis (National Academy of Engineer-
ing, 1970).
And, it is in response to this need that NASA is contributing to the
field of cardiology.
Throughout the remaining portion of this document, examples of
selected NASA contributions to cardiology are discussed. While some
of these illustrate the manner in which the generation of technology,
either instrumentation or techniques, provides new alternatives and
focus for professional progress, others are illustrative of the applica.-
tion of technology to specific problems confronting the medical com-
munity.
Electrode technology. Electrocardiography has found increasing
use since its invention in 1903 by William Eithoven. Since the electro-
cardiogram (EKG) is an excellent means of determining heart muscle
activity such as disturbances of rhythm (arhythmia), damage to the
heart muscle, imbalance between the two sides of the heart where one
side is overloaded, and various kinds of poisoning that affect the heart
muscles (e. g. , digitalis or potassium), NASA has used it to monitor
and observe astronauts during training and in space flight.
The EKG is the record of electrical changes in the heart muscle.
The very weak electrical signals produced by the heart are detected by
electrodes placed on the body. These signals are then relayed to a
device which amplifies and records them. The electrode has been the
major problem-causing mechanism of taking EKG's. There are basi-
cally two difficulties: (1) the electrode must be able to pick up the
heart's weak electrical signal with little disturbance or artifact noise,
and (2) the electrodes must be comfortable so that they may be worn
for great lengths of time.
Because monitoring the EKG is such a basic and necessary task,
NASA has put great effort into developing electrode technology. Even
though the electrocardiogram had been in clinical use for more than
fifty years, it was discovered during preparation for the Mercury
Program that no existing electrodes were acceptable for space flight.
This was mainly due to the electrode paste, or electrolyte, which
caused skin irritation and dried out, thus losing its conductivity and
effectiveness (Jones, 1966). The need for acceptable electrodes thus
produced a series of advances in electrode technology that can be
illustrated by examining the NASA Tech Briefs* describing them:
* Improved Electrode Gives High-Quality Biological
Recordings (TB 64-10025)
* Improved Conductive Paste Secures Biomedical
Electrodes (TB 65-10015)
* Rugged Pressed Disk Electrode Has Low Contact
Potential (TB 65-10320)
* Improved Electrode Paste Provides Reliable
Measurement of Galvanic Skin Response (TB 66-10049)
* Gelatin-Coated Electrodes Allow Prolonged Bio-
electronic Measurements (TB 66-10055)
* Integrated Skin Electrode for Electrocardiography
is Expendable (TB 66-10118)
* Spray-On Electrodes Enable ECG Monitoring of
Physically Active Subjects (TB 66-10649)
* Quick Don-Doff Electrode Pastes (TB 69-10598)
* Ultra-Flexible Biomedical Electrodes and Wires
(TB 70-10420)
* Improved Biomedical Electrode (TB 72-10642)
* A New Dry Biomedical Electrode (TB 73-10146)
One of the mechanisms used by the NASA Technology Utilization
Office to acquaint industry and the public with the technical content
of an innovation derived from the space program.
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Since satisfactory signal detection has been achieved, electrode
technology has reached a point where research is now concentrated on
skin compatibility and wearer comfort (Rositano, 1973). For instance,
research being conducted at NASA Ames Research Center is directed
toward new electrodes that may be worn for extremely long periods of
time with minimum skin irritation or wearer discomfort. One experi-
ment, done in conjunction with bedrest studies at Ames, involves the
use of conductive knit mesh electrodes. The results appear to hold
great promise as the electrodes have been worn for extended periods
with no signs of skin irritation and very little inconvenience or discom-
fort to the subjects. Development of electrodes such as these that can
be worn for long periods of time with no ill affects have direct implica-
tions for clinical application with patients requiring constant and long-
term care.
The real-time contourograph display system. Electrocardiograph
results, or tracings, traditionally have been displayed either on a con-
tinuous paper strip or by single beats appearing on a cathode ray tube
similar to a television screen. The former method typically produces
miles of paper that must be manually scanned for interpretation, while
the latter provides no means of comparison since only one beat is visi-
ble at any given time.
A new approach to monitoring EKG signals, contourography, was
developed by George N. Webb and Richard E. Rogers (Webb and Rogers,
1966 and Webb, 1974). Contourography is a technique for presenting
repetitive data in a highly informative manner. In effect, contourog-
raphy stacks succeeding cycles of data one below the other. This makes
any major change in the data immediately apparent in the overall con-
tourogram pattern. Electrocardiograph tracings lend themselves to
contourographic format because each cardiac cycle, or heartbeat, has
a characteristic waveform (Wolthuis, 1973).
A contourograph device displaying a continuous, real-time EKG
contourogram was developed by Technology, Incorporated, under con-
tract to the NASA Lyndon B. Johnson Space Center (Golden, 1970).
This real-time contourograph system has several important advantages
over previous systems of monitoring electrocardiograms, including:
* The EKG contourogram is generated continuously, in
real-time, so that instantaneous heart rate can be
read directly from the cathode ray tube, as can any
conspicuous variation in the EKG pattern.
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* The system permits three different viewing modes,
including a standard clinical EKG display (single
beats only appearing).
* To a trained observer, the system presents a great
deal of information in an extremely concise form.
Because the real-time contourograph allows constant monitoring
and quick identification of variations in the EKG, it is being used suc-
cessfully to monitor astronauts while in flight and during pre- and
post-flight tests.
Technology, Incorporated, recognizing the potential market value
of the real-time contourograph, is currently performing market
studies for the commercialization of a slightly modified version of the
NASA instrument (see Figure 3). Intended for cardiac monitoring, the
system would have two potential applications: direct patient monitoring,
such as in an intensive care unit; and the playback of recorded EKG
data, enabling a physician to analyze hours of data in minutes (Pugh,
1973).
cp TouROsCOPE
Figure 3. The Real-Time Contourograph Display System.
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Detecting arteriosclerotic changes in blood vessels. As part of the
National Heart, Blood Vessel, Lung and Blood Program, the National
Heart and Lung Institute has established several Arteriosclerosis Spe-
cialized Centers of Research. Since there has been no noninvasive
means of accurately detecting arteriosclerotic changes in vessels, one
effort being undertaken by these Centers is the development of instru-
mentation to diagnosis and characterize athrosclerotic plaques (Na-
tional Heart and Lung Institute, National Program, 1973).
The Specialized Center of Research at the University of Southern
California is conducting a study to determine the effects of diet, exer-
cise, and other factors on the buildup of cholesterol in blood vessels.
As part of this study, a noninvasive technique to monitor changes in
vessel roughness and plaque buildup was needed.
The Jet Propulsion Laboratory (JPL), working with the University,
is developing such a technique utilizing digital computer processing of
X-ray photos, a process derived from technology developed at JPL to
correct distortions in images received from the television cameras of
the Ranger, Mariner, and Surveyor spacecraft (Selzer, 1966). * The
technique is entirely noninvasive, except for the injection of a dye into
the blood stream. After the dye is injected, X-rays are taken and pro-
cessed using the enhancement technique (Selzer, 1974). They are then
examined to determine plaque buildup and vessel roughness.
The development of this technique to monitor changes in the blood
vessels is of vital importance to continued research on the effects of
cholesterol. In this way, it is also instrumental in clarifying the role
of personal habits, such as diet and exercise, in arteriosclerotic
heart disease.
This is yet another application of the process which is already finding
application in the medical community for automating the calculation of
left-ventricular blood volume; detecting more accurately the begin-
nings of cancer and other abnormalities and disfunctions; analyzing
tooth X-rays; and processing photos of chromosomes. These appli-
cations are in addition to those occurring outside the medical commu-
nity, such as the inspection of printed circuit boards.
Automated blood pressure measuring system. "The measurement
of blood pressure in the human body is probably the most widely used
diagnostic tool in the practice of medicine today" (Smith, 1964). To
the physician, blood pressure measurement can reveal malfunctions
of the heart and substantiate diseases of the blood-carrying ducts,
such as arteriosclerosis and congenital cardiovascular anomalies. In
addition, many other organic ailments, pulmonary and endocrine dis-
orders, and disorders of the nervous system can manifest themselves
in blood pressure variations (Smith, 1964).
The most common method of measuring blood pressure is by using
a sphygmomanometer, a well-known instrument that consists of a col-
umn of mercury supported by the air pressure in an inflatable cuff.
The cuff is wrapped around a limb and inflated. When the pressure is
just enough to obliterate the pulse, the height of the column of mercury
indicates the systolic blood pressure (the pumping or active phase of
the heartbeat). When the pressure in the cuff is reduced to the dia-
stolic blood pressure (the resting or passive phase of the heartbeat),
a slapping sound is heard over the artery beyond the cuff. These char-
acteristic sounds are called Korotkov sounds, or K-sounds, for the
man who first detected them.
NASA's Project Skylab scheduled several experiments that required
an automated, noninvasive system for blood pressure measurement.
The system had to meet four requirements in measuring blood pres-
sure: (1) at rest and during stress procedures; (2) before, during, and
after exercising; (3) in normal and zero gravity environments; and (4)
with an accuracy equal to accepted clinical techniques (Wolthuis, et al.
1971).
After an examination of various types of blood pressure measure-
ment techniques, researchers chose to adapt the Korotkov sound tech-
nique for implementation into the system. This decision was made
because of the K-sound's clinical and historical precedence, adapta-
bility to automation, and relative insensitivity to motion-caused
artifact, or interference, as compared to ultrasonic techniques.
The system developed consists of an arm cuff which is rapidly in-
flated to a pressure sufficient to stop blood flow to the forearm, and
then it is slowly depressurized. During this depressurization, the
Korotkov sounds are picked up by a microphone placed under the cuff,
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amplified, and then fed to a processor and decision logic system (see
Figure 4). The product of this decision logic system is the systolic
and diastolic blood pressures being displayed on a digital readout
mechanism.
Air Pressure Source
c- ---- Arm Pressure Cuff
And Regulator
Transducer
r  ress re uff Korotkov Sound Systolic And
Microphone Processor and Diastolic Blood
Decision Logic Pressure
Microphone
Figure 4. Automated Analysis of Blood Pressure Measurements.
This automated blood pressure measurement technique has been
adapted by SCI Systems, Incorporated, under contract to the Lyndon
B. Johnson Space Center, and is now being marketed as part of their
TELECARE Emergency System (Castle, 1973). TELECARE is a unit
that has, in one package, all the components that could reasonably be
used in an acute cardiopulmonary situation. It contains: a respira-
tory resuscitation system; a fifteen-minute oxygen supply derived
from a chlorate candle developed from space technology; an electro-
cardiogram display and telemetry system; a defibrillator for external
heart stimulation; and the blood pressure measurement system sim-
ilar to that developed for Skylab, which can frequently be used in
many situations where there is high background noise or when the
patient is in shock, which diminishes Korotkov sounds. TELECARE
units are now being used in twenty-eight rescue vehicles in Houston,
Texas (see Figure 5).
17
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Figure 5. The TELECARE Unit.
NASA Biomedical Application Teams. In 1966 the NASA Technol-
ogy Utilization Office established a program using an active and
directed methodology for the dissemination and utilization of technical
information. Interdisciplinary teams of scientists were formed to
bridge the communication gap between the developers and users of
technology. Of special interest to the area of cardiology are the ef-
forts to bring together NASA's physical scientists and the medical
world. For this purpose, Biomedical Application Teams have been
established. Each team consists of individuals in the biological and
physical sciences who are practicing, informed, and who can commu-
nicate readily across interdisciplinary lines. All are equipped with
This page is reproduced at the
back of the report by a different
reproduction method to provide
better detail.
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firsthand knowledge of areas of active research at NASA and contractor
facilities and are familiar with NASA's collection of technical informa-
tion. In short, the teams represent a specialized human link between
NASA, its research centers and contractors, and the biological and
medical communities (Castles, 1971). This relationship is carried out
to whatever extent the situation demands, short of performing the
actual operations for the potential user. For example, information
alone may suffice the medical researcher, while a medical practitioner
may need assistance in experimental design, interpretation of aero-
space technology, or help in applying for funds to accomplish his goals.
NASA's Technology Utilization Office has three Biomedical Appli-
cation Teams presently in operation. These are located at the
Research Triangle Institute, Durham, North Carolina; Southwest
Research Institute, San Antonio, Texas; and Stanford University School
of Medicine, Palo Alto, California.
The team at Stanford University School of Medicine, Cardiology
Division, is of special interest because it directs primary emphasis
toward the identification, acquisition, and solution of research and
clinical problems in the area of cardiovascular medicine. The ap-
proach used at Stanford involves a close working relationship, on a
few in-depth studies, between scientists and engineers at NASA Ames
Research Center and physicians and engineers of the team (Stanford
University School of Medicine, 1973). It is hoped that by working on a
few detailed studies, the Stanford team can make significant contribu-
tions to the area of cardiology using NASA-developed technology.
The ultrasonoscope. For a patient, the use of noninvasive tech-
niques for diagnosis of illness has obvious advantages over invasive
techniques, or those that require penetration of the body. The trauma,
both physical and emotional, that occurs with invasion can be ex-
tremely detrimental. For the physician and engineer, noninvasive
techniques present a special problem that is analogous to a television
repairman trying to troubleshoot a TV without opening the cabinet
(Fryer, 1973). Ultrasound is one technique now being explored that
has great potential in the area of noninvasive diagnosis.
In an ultrasonoscope, the instrument used for ultrasound studies,
an ultrasonic transducer emits a signal that travels through the skin
and chest wall to the heart, is reflected from the front and back walls
of the heart, and travels back to the same transducer. The signal
echoes are then processed so that a quantitative readout of information
concerning heart size and volume can be calculated (U. S. Congress,
House, 1973). Ultrasound has been shown clinically useful in the diag-
nosis of aortic, mitral and tricuspid valve disease, foreign bodies in
the heart, the presence of pericardial effusion, and specific congenital
heart defects (Stanford University School of Medicine, 1972).
During an active program of ultrasonic diagnosis at Stanford Uni-
versity Hospital, it was found that commercially available equipment
was bulky and was potentially hazardous from an electrical shock
standpoint, especially when used with electrically sensitive patients
such as those found in a cardiac catheterization laboratory or in a
newborn nursery (Stanford University School of Medicine, 1973). Thus,
Robert Lee of the NASA Ames Research Center and Dr. Richard Y.
Popp at Stanford University are refining the ultrasonoscope used for
noninvasive study of the heart.
The prototype now being tested has been reduced in size so that it
is highly mobile and easily transported to the bedside or the cardiac
catheterization laboratory. Also, it has been independently tested to
ensure its electrical safety--a point of paramount concern in medical
instruments and a major advantage of the NASA-developed ultrasono-
scope.
The device has been used at Stanford in the newborn nursery and
the pediatric ward where patients are housed in a controlled environ-
ment, often in Isolettes tha.t have other electrical systems for con-
trolled temperature and humidity. In addition, patients are usually
monitored with other externally powered instrumentation. Since it is
not feasible to disconnect all of this equipment during an ultrasonic
examination, dangerous leakage currents can be transmitted through
the heart and body if multiple alternating current devices are used
simultaneously. The NASA battery-operated ultrasonoscope com-
pletely avoids this hazard, and ultrasonic information can safely be
obtained while life-support systems continue (Stanford University
School of Medicine, 1973).
Additional clinical evaluation studies are being carried out at
Stanford, and the diagnostic quality of the prototype is being compared
with presently available units (Miller, 1973). These evaluations will
provide data which will serve in advancing knowledge in the emerging
area of ultrasonic studies.
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To complement the activities of the Biomedical Application Teams,
the Technology Utilization Office also sponsors a variety of biomedical
engineering application projects at medical research centers around
the country. A number of these are directly related to cardiovascular
research. The NASA funding of these application projects has produced
significant developments in the attack against heart disease, including
advancements in pacemaker technology.
The rechargeable cardiac pacemaker., The natural pacemaker of
the heart is the sinu-arterial node from which a wave of contraction
spreads through the heart muscle with each beat. When the natural
heartbeat fails or becomes irregular because of heart disease, an arti-
ficial.pacemaker which delivers small, regular electric shocks can be
life-saving. In the United States, approximately 30, 000 pacemakers
are implanted each year; another 30, 000 units are implanted each year
in the rest of the world (McClure, 1972).
The average life expectancy for pacemakers up to now has been
about twenty-two months, after which time their mercury cell power
supply is depleted. A surgical operation is then required to remove
the pacemaker and implant a new device. Obviously, this repeated
surgery can be traumatic, as can be the expense incurred. Payments
under Medicare, for example, typically exceed $2, 000 for each pace-
maker replacement.
Another disadvantage of these units is that their relatively large
size and weight cause discomfort and prevent hiding the device cos-
metically in patients, especially small children and persons with thin
skin.
Scientists and doctors at the Johns Hopkins University Applied
Physics Laboratory have developed, under the partial sponsorship of
NASA, a new heart pacemaker which is rechargeable and much smaller
than conventional units (see Figure 6). The new equipment uses elec-
trical and electronic components first designed by NASA for use in
spacecraft (NASA, 1973).
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Figure 6. The Rechargeable Cardiac Pacemaker (Right),
Shown with Recharging Unit (Left).
The new device eliminates the need for frequent replacement by
using rechargeable nickel-cadmium cells which are the result of
many years of development for spacecraft applications. For ninety
minutes each week the patient puts on a special vest that recharges
the pacemaker battery by an alternating magnetic field transmitted
through the skin, with no harmful effects (see Figure 7). Since it is
recharged weekly, only one cell is required, and the size of the pace-
maker can be reduced to half the thickness and 25 percent the volume
of previously available models.
This page is reproduced at the
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Figure 7. Patient Wearing Vest to Recharge Pacemaker.
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Another advantage of the newly developed device is that it is immune
to electrical interference sources, such as microwave ovens, car igni-
tions, and radars, that sometimes stop conventional pacemakers from
operating.
Even with the rechargeable pacemaker being commercially avail-
able, work is continuing to improve pacemaker technology. NASA is
providing technical and financial support for the utilization of the most
advanced techniques of miniaturized, hybrid, solid state circuitry, as
derived from spacecraft applications. This research will further re-
duce the size of the pacemaker and increase its reliability (McClure,
1972).
Conclusion
This brief examination of NASA contributions to the field of cardi-
ology provides a unique perspective for understanding some of the
larger issues involved in technology transfer. This document has
described a number of NASA innovations that have broadened both the
knowledge and the technology base of cardiology. In the aggregate,
the significance of NASA's activities in cardiology can be found in the
Agency's systematic approach to capturing, refining, and preserving
technological gains of marginal interest to the mainstream of aero-
space science, engineering, and flight requirements, but of great
interest in terms of improving the quality of health care.
The point to be made here is that few of these innovations, in their
initial form, can be expected to enjoy sustained and widespread use.
This is because of the course of development of medical technology and
its subsequent introduction into the marketplace. This course of de-
velopment consists of: (1) initial research, development, evaluation,
and prototype testing; (2) limited clinical testing and evaluation, with
continual refinement; and (3) gradual introduction into routine clinical
practice in several locations. It is only after these three phases are
completed that a new device or technique finds its way into general
use (Jones, 1966).
The rate of progression through these three phases depends upon
the fundamental medical technology involved in the innovation. For
rapid progression, the innovation must be based on technology that is
widespread and presently understood by a majority of the practicing
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medical profession. If the innovation involves new medical technology,
the progression will be slow because of the educational time required
to incorporate such technology into general practice.
Further, it is the medical profession which must finally carry an
innovation through this progression. The essential consideration for
NASA is that relevant aerospace R&D results have been transformed
and made available to the community charged with responsibility for
progress in combating heart disease. As such, the innovations pro-
vide new alternatives and focus for professional progress in the field.
In fact, this is the usual way in which the results of NASA R&D
impact industrial, commercial, and public interests that lie outside
aerospace. Rapid and intact adoption of any innovation occurs only
when there is a lack of activity in the field, a vacuum. In application
areas where there is strong professional and commercial activity,
there is no vacuum. Thus, it is the "know how" embodied in aerospace
innovation that most often represents an opportunity for improvements,
not the specific innovation. This case study has examined only one
arena in which that "know how" is transferring to a user community as
a direct result of NASA's commitment to the secondary use of aero-
space technology.
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